DFTX · Definium Therapeutics, Inc. · Executive Compensation
Market Cap
$5.14B
Shares
134.37M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Robert Barrow | Chief Executive Officer | $12,767,442 |
| Brandi L. Roberts | Chief Financial Officer | $5,116,362 |
| Daniel Karlin | Chief Medical Officer | $4,001,258 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Robert Barrow | Chief Executive Officer | $2,669,010 |
| Daniel Karlin | Chief Medical Officer | $1,330,319 |
| Mark Sullivan | J.D. Chief Legal Officer Schond Greenway Former Chief Financial Officer | $1,161,107 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mark Sullivan | J.D. Chief Legal Officer Schond Greenway Former Chief Financial Officer | $1,080,394 |
| Daniel Karlin | Chief Medical Officer | $1,037,272 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| JR Rahn | Former Chief Executive Officer | $14,991,351 |
| Robert Barrow | Chief Executive Officer | $11,889,466 |
| Daniel Karlin | Chief Medical Officer | $4,905,942 |
| Miri Halperin Wernli | Executive President | $2,663,528 |
| Stephen Hurst | Former Co-Chief Executive Officer | $1,059,315 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| JR Rahn | Former Chief Executive Officer | $1,234,493 |
| Miri Halperin Wernli | Executive President | $996,147 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Roger Adsett | Director | Appointed | 2026-06-12 |
| Carol A. Vallone | Director | Appointed | 2026-06-12 |
| David Gryska | Director | Appointed | 2026-06-12 |
| Andreas Krebs | Director | Appointed | 2026-06-12 |
| Suzanne Bruhn | Director | Appointed | 2026-06-12 |
| Roger Crystal | Director | Appointed | 2026-06-12 |
| Robert Barrow | Director | Appointed | 2026-06-12 |
| Roger Adsett | director | Appointed | 2026-01-29 |
| David Gryska | member of the Board | Appointed | 2025-06-16 |
| Andreas Krebs | member of the Board | Appointed | 2025-06-16 |
| Carol A. Vallone | member of the Board | Appointed | 2025-06-16 |
| Suzanne Bruhn | member of the Board | Appointed | 2025-06-16 |
| Roger Crystal | member of the Board | Appointed | 2025-06-16 |
| Robert Barrow | member of the Board | Appointed | 2025-06-16 |
| Brandi L. Roberts | Chief Financial Officer | Appointed | 2025-05-27 |
Key facts
CIK
1813814
CUSIP
24477V105
13F (30d)
237 filings
237 filers
Visit website
Investor relations